Sanofi (EPA:SAN)

Market Cap	93.73B
Revenue (ttm)	45.93B -5.2%
Net Income	9.11B +102.2%
EPS	7.39 +105.9%
Shares Out	1.21B
PE Ratio	14.86
Forward PE	9.42
Dividend	3.92 (4.92%)
Ex-Dividend Date	May 12, 2025

Volume	503,989
Average Volume	1,766,521
Open	78.29
Previous Close	77.54
Day's Range	76.83 - 78.30
52-Week Range	76.15 - 110.88
Beta	0.40
RSI	35.44
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Euronext Paris
• Ticker Symbol: SAN

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.